Walgreens once ruled. Then came Amazon, Theranos — and some costly betsByFrancisco VelasquezUpdatedMarch 7, 2025
Target's price hikes, Walmart's China strategy, and Starbucks' tough love: Retail news roundupByFrancisco VelasquezPublishedMarch 7, 2025
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundupByBruce GilPublishedMarch 7, 2025
Big Pharma wants to bring back a tax break that could save it $15 billionByBruce GilPublishedMarch 6, 2025
Best Buy is following Walmart’s lead, yanking Amazon's playbookByFrancisco VelasquezPublishedMarch 6, 2025
The price to listen to Alex Cooper and Howard Stern on SiriusXM might change — thanks to tariffsByBruce GilPublishedMarch 6, 2025
Trump's trade war and Elon Musk's DOGE caused a 245% surge in layoff announcementsByWilliam GavinUpdatedMarch 6, 2025
Delta Air Lines is helping make a new plane and it looks kind of like a Stealth bomberByKevin WilliamsUpdatedMarch 7, 2025
Now playing Ozempic competitor in the works at Amgen reaches late-stage clinical trialsPublishedMarch 5, 2025
Elon Musk's SpaceX says it's not trying to take over Verizon's $2.4 billion FAA contractByWilliam GavinUpdatedMarch 5, 2025
Now playing Amgen just got one step closer to bringing its Ozempic competitor to marketByBruce GilUpdatedMarch 5, 2025
